MedTech M&A Intelligence
Before the first call, know exactly what you're worth — and to whom.
InflexionBI turns 400+ MedTech acquisitions and 700+ VC funding rounds into a negotiation brief specific to your company — so you walk in with evidence, not guesswork.
Five modules. One briefing before the room.
From market reality to negotiation posture — structured intelligence at every stage of your process.
Industry Insights
Market-wide acquisition intelligence with hyper-filterable charts, graphs, and tables. Track deal activity by stage, sector, product type, amount paid, and more. Identify where money clears, who buys, and under what conditions — then save and share views across your team.
User Insights
Personalized acquisition readiness benchmarked against your exact profile. Your Acquisition Readiness Score tracks over time as your company evolves. See which acquirers are your strongest fits, where they hesitate, and which exit pathway is most defensible for your situation.
VC Insights
Private financing intelligence for MedTech companies seeking institutional funding. Score investor fit by stage, sector, and check size. Benchmark your round against 700+ real Form D filings and map how capital flows by stage and use of proceeds.
Acquisition Defense
Quantify your premium defense burden and stress-test your negotiation posture before diligence begins. See your top buyer objections ranked by severity, each buyer's specific attack surface, and a pre-process negotiation brief that tells you exactly where you're exposed.
Financial Models
Valuation and cash-flow modeling for fundraising and exit prep. Build a multiple-based valuation, project enterprise value across Bear, Base, and Bull scenarios, and run the NPV a strategic buyer would see — with more models landing over time.
What you'll know before the first call
Not market awareness. Personal positioning — filtered to your sector, your stage, your target valuation, your likely buyers.
Where buyers will attack your valuation
Your top objections ranked by severity — with the exact trigger, the historical anchor range, and what to expect in the room before the first call.
What you're actually worth, and to whom
Your target valuation benchmarked against 25 comparable exits. Clearing probability stated. Which acquirers have paid at or above your ask — and which haven't.
Which acquirers and investors are your best fits
Every likely buyer and investor scored for fit, with signals for why they'd engage and why they'd hesitate — so your outreach targets the right rooms.
How defensible your negotiation posture is
A four-part pre-process brief: your opening position, your primary exposure, the move that changes your outcome, and whether market timing is a tailwind or headwind.